文献速递脑血管病

循环环状RNA作为急性缺血性卒中诊断与预后预测的生物标志物

Circulating Circular RNAs as Biomarkers for the Diagnosis and Prediction of Outcomes in Acute Ischemic Stroke.
PubMed 文献 · Stroke · 2019-11-06

该研究通过微阵列在发现队列(3例vs3例)中筛选差异表达的循环环状RNA(circRNA),并在验证队列(36例vs36例)和复制队列(200例vs100例)中用定量PCR确认。中国人群急性缺血性卒中(AIS)患者有3种circRNA上调,联合诊断AIS的曲线下面积为0.875(特异性91%,敏感性71.5%);治疗7天内3种circRNA变化率联合预测卒中结局的曲线下面积为0.960。circPDS5B在淋巴细胞和粒细胞中升高,circCDC14A仅在粒细胞中升高。

要点

  • 3种循环circRNA联合诊断AIS的AUC为0.875,特异性91%,敏感性71.5%。
  • 治疗7天内3种circRNA变化率联合预测卒中结局的AUC为0.960。
  • circPDS5B和circCDC14A升高可能源于淋巴细胞和粒细胞增多。

核心结论

  • 3种circRNA可作为AIS诊断和卒中结局预测的生物标志物。

研究设计与样本

  • 研究采用circRNA微阵列在发现队列(3例vs3例)中筛选差异表达的循环circRNA,并在验证队列(36例vs36例)和复制队列(200例vs100例)中用定量PCR确认。

主要发现

  • 中国人群AIS患者较健康对照有3种circRNA上调。
  • 3种circRNA联合诊断AIS的曲线下面积为0.875,特异性91%,敏感性71.5%。
  • 治疗7天内3种circRNA变化率联合预测卒中结局的曲线下面积为0.960。
  • AIS患者circPDS5B在淋巴细胞和粒细胞中显著升高,circCDC14A仅在粒细胞中显著升高。

关键数值与推荐

  • 诊断AIS:3种circRNA联合的AUC为0.875,特异性91%,敏感性71.5%。
  • 预测卒中结局:治疗7天内3种circRNA变化率联合的AUC为0.960。

临床怎么用

  • 循环circRNA联合检测有望辅助AIS诊断和预后评估,但需进一步验证。

局限性

  • 研究基于中国人群,发现队列样本量小(3例vs3例),外部普适性需验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Circular RNAs (CircRNAs) show promise as stroke biomarkers because of their participation in various pathophysiological processes associated with acute ischemic stroke (AIS) and stability in peripheral blood. Methods- A circRNA microarray was used to identify differentially expressed circulating circRNAs in a discovery cohort (3 versus 3). Validation (36 versus 36) and replication (200 versus 100) were performed in independent cohorts by quantitative polymerase chain reaction. Platelets, lymphocytes, and granulocytes were separated from blood to examine the origins of circRNAs. Results- There were 3 upregulated circRNAs in Chinese population-based AIS patients compared with healthy controls. The combination of 3 circRNAs resulted in an area under the curve of 0.875, corresponding to a specificity of 91% and a sensitivity of 71.5% in AIS diagnosis. Furthermore, the combination of change rate in 3 circRNAs within the first 7 days of treatment showed an area under the curve of 0.960 in predicting stroke outcome. There was significant increase in lymphocytes and granulocytes for circPDS5B (circular RNA PDS5B) and only in granulocytes for circCDC14A (circular RNA CDC14A) in AIS patients compared with healthy controls. Conclusions- Three circRNAs could serve as biomarkers for AIS diagnosis and prediction of stroke outcomes. The elevated levels of circPDS5B and circCDC14A after stroke might be because of increased levels in lymphocytes and granulocytes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Zuo L, Zhang L, Zu J, et al. Circulating Circular RNAs as Biomarkers for the Diagnosis and Prediction of Outcomes in Acute Ischemic Stroke. Stroke. 2019. PMID: 31690252. doi:10.1161/STROKEAHA.119.027348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。